Provided by Tiger Trade Technology Pte. Ltd.

enVVeno Medical Corp.

9.05
-0.2700-2.90%
Post-market: 8.88-0.1700-1.88%17:28 EDT
Volume:39.22K
Turnover:340.83K
Market Cap:6.29M
PE:-0.36
High:9.44
Open:9.42
Low:7.01
Close:9.32
52wk High:35.70
52wk Low:7.01
Shares:694.80K
Float Shares:569.40K
Volume Ratio:0.59
T/O Rate:6.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-24.8994
EPS(LYR):-33.0600
ROE:-58.53%
ROA:-36.67%
PB:0.30
PE(LYR):-0.27

Loading ...

enVVeno Medical trading resumes

TIPRANKS
·
Yesterday

NASDAQ Trade Halt Volatility Trading Pause at 11:24 Am

Reuters
·
Yesterday

enVVeno Medical Posts H.C. Wainwright Conference Presentation for On-Demand Viewing

Reuters
·
Sep 11

enVVeno Medical CEO Presents at Virtual Investor “Why Now” On-Demand Conference

Reuters
·
Aug 27

enVVeno Medical Wins FDA IDE Approval for enVVe Pivotal Trial in Deep Venous Insufficiency

Reuters
·
Aug 27

enVVeno Medical Corp: Files for Mixed Shelf of Upto $100 Mln -SEC Filing

THOMSON REUTERS
·
Aug 22

enVVeno Medical files $100M mixed securities shelf

TIPRANKS
·
Aug 22

enVVeno Medical: May Offer and Sell Securities for up to $100 Mln - SEC Filing

THOMSON REUTERS
·
Aug 22

enVVeno announces publication of independent health economic study

TIPRANKS
·
Aug 04

enVVeno Cites Journal of Vascular Surgery Study Showing Venous Valve Therapy Saves More than $32,000 Per Patient over Five Years

Reuters
·
Aug 04

enVVeno Medical Q2 EPS $(5.37) Up From $(11.55) YoY

Benzinga Earnings
·
Jul 31

enVVeno Medical Corp: Tavve Pivotal Study Expected to Begin Enrolling Patients During the Second Half of This Year

THOMSON REUTERS
·
Jul 31

enVVeno Medical Corp: Company Enters the Second Half of 2026 with Tailwinds from an FDA Ide Approval

THOMSON REUTERS
·
Jul 31

enVVeno Medical Corp: Cash Runway Extending into the Third Quarter of 2027

THOMSON REUTERS
·
Jul 31

enVVeno Medical: Net Loss Q2 2026 was $3.6 Million, or $5.37 Per Basic and Diluted Share

THOMSON REUTERS
·
Jul 31

enVVeno Medical Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

enVVeno Net Loss Narrows 46% to $3.6 Million in Q2 FY26

Reuters
·
Jul 31

enVVeno Medical Corp Expected to Post a Loss of $4.69 a Share - Earnings Preview

Reuters
·
Jul 28

enVVeno Medical highlights newly issued U.S. patent

TIPRANKS
·
Jul 15

Envveno Medical Wins First US Patent Covering Envve System

Reuters
·
Jul 15